COAST therapy for advanced prostate or other solid tumors
Part of Cancer clinical trials.
This early-phase trial tests the COAST therapy approach in people with advanced solid tumor cancers or advanced prostate cancer that has continued to grow despite standard treatments. The study aims to see how well the treatment works and whether it is safe enough to continue studying.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have advanced solid tumor cancer (any type) or advanced prostate cancer, and prostate cancer must have PSA of at least 0.1 ng/mL.
- You need a confirmed cancer diagnosis from pathology (biopsy) or a clinician note that documents the diagnosis.
- Your cancer must have measurable or trackable disease using scans, blood tests, or a radionuclide imaging test.
- You must be 18 or older and able to do daily activities fairly well (ECOG 0–2).
- Your blood counts and organ labs must be within study limits (liver tests, kidney function, white blood cells, platelets, and hemoglobin).
- You must not have certain recent treatments or major health problems (like unstable heart issues, uncontrolled infections, or recent surgery/radiation/investigational therapy within 28 days).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two new drugs, P1101 and P1801, in people with advanced solid tumors that have not responded to standard treatments. The goal is to see if the combination is safe and effective.
This study tests an experimental drug called PHST001 for people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if it is safe and if it can help shrink tumors.
This trial tests a new medication for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if the drug can shrink tumors or slow their growth.
This trial tests a new drug called SOT109 for people with advanced colorectal cancer that can't be removed by surgery or has spread. The goal is to see if it is safe, how well it works, and how the body handles it.
This trial tests a new drug called CS2009 for people with advanced solid tumors that haven't responded to other treatments. It aims to see if the drug is safe and effective.
This early-phase trial tests a new drug called ASD141 for people with advanced solid tumors that no longer respond to standard treatments. The goal is to see if it is safe and how well it works against the cancer.
Hear when a new Prostate Cancer Recurrent trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.